Amarin Corp Plc (AMRN)

[MedResCollab]

kc44,

In our analysis of Amarin we came across them. CaPre is weak, and some of the data presented are misleading. It will at most reduce TG by 10-15%. It contains a great deal less EPA/DHA, while although in a better absorbed form than ethyl ester is far too small a dose to matter. Look at how much better Lovaza or Vascepa does with even a little food. No one will prescribe it.

Matinas on the other hand, should worry you.